On June 26th, Galonline reported that French pharmaceutical giant Sanofi (SNY.US) fell 3.25% to $48.48. In terms of news, insiders revealed that Sanofi has launched a preliminary bidding for its $20 billion consumer health division. At the same time, Sanofi is preparing for the possible IPO of the business. The company has requested potential bidders to submit their first round of quotes before mid-July. Acquisition companies Advent International and PAI Partners of France are seen as enthusiastic buyers, while Blackstone Group, CD&R, CVC and TPG are also reportedly interested in bidding.
美股异动｜赛诺菲跌3.25% 有意出售旗下消费者保健部门
US stocks fluctuate | Sanofi fell 3.25%, intending to sell its consumer healthcare department.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.